Botulinum toxin in orofacial pain management: INfORM/IADR recommendations
Authors:
- Matteo ValMatteo Val
- Lene Baad-HansenLBLene Baad-Hansen
- Laura NykänenLNLaura Nykänen
- Giancarlo De La Torre CanalesGCGiancarlo De La Torre Canales
- Donald R. NixdorfDNDonald R. Nixdorf
- Matteo PollisMPMatteo Pollis
- Anna ColonnaAnna Colonna
- Claudia RestrepoCRClaudia Restrepo
- Nikola StanisicNSNikola Stanisic
- Aya Al-SalihAAAya Al-Salih
- Chris PenlingtonCPChris Penlington
- 22 October 2026
- journal article
- Published by Taylor & Francis in Cranio®
- p. 1-6
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Pharmacotherapy and non-invasive neuromodulation for neuropathic pain: a systematic review and meta-analysisThe Lancet Neurology, 2025
- Botulinum Toxin-A for the Treatment of Myogenous Temporomandibular Disorders: An Umbrella Review of Systematic ReviewsDrugs, 2024
- Is low dose of botulinum toxin effective in controlling chronic pain in sleep bruxism, awake bruxism, and temporomandibular disorder?Cranio®, 2021
- Does botulinum toxin have any role in the management of chronic pain associated with bruxism?Cranio®, 2021
- Botulinum toxin and occlusal splints for the management of sleep bruxism in individuals with implant overdentures: A randomized controlled trialThe Saudi Dental Journal, 2021
- Current status of the application of botulinum toxin as a treatment option for trigeminal neuralgiaCranio®, 2020
- The binding of botulinum neurotoxins to different peripheral neuronsToxicon, 2018
- Is there enough evidence to use botulinum toxin injections for bruxism management? A systematic literature reviewClinical Oral Investigations, 2017
- Review of a Proposed Mechanism for the Antinociceptive Action of Botulinum Toxin Type ANeuroToxicology, 2005
- Randomized controlled trial of botulinum toxin A for chronic myogenous orofacial painPain, 2002